HUA MEDICINE-B (02552) has granted 200,000 stock options.
Hua Ling Medical - B (02552) announced that on August 21, 2026, the company granted 200,000 share options to an employee (the grantee) under the company's share option plan, which was conditionally approved and adopted on August 26, 2018, and became effective on September 14, 2018, subject to the acceptance by the grantee. The share options entitle the grantee to subscribe for a total of 200,000 new shares of the company, each with a par value of $0.001.
HUA MEDICINE-B (02552) announced that on August 21, 2026, the company granted 200,000 stock options to an employee (the grantee) under the companys stock option plan, which was conditionally approved and adopted on August 26, 2018, and has been effective since September 14, 2018, pending acceptance by the grantee. The stock options grant the grantee the right to subscribe for a total of 200,000 new shares of the company's capital stock, each with a par value of $0.001.
Related Articles
Huatai (06886): Reissue of the "Securities and Futures Business License"
ASCLETIS-B (01672) issued a profit warning, expecting a mid-term shareholder loss of approximately 319.7 million yuan, an increase of about 263.5% year-on-year.
Zijin Mining Group (02899) announced its mid-term results, with a net profit attributable to shareholders of approximately 39.17 billion yuan, a year-on-year increase of 68.17%.
Huatai (06886): Reissue of the "Securities and Futures Business License"
ASCLETIS-B (01672) issued a profit warning, expecting a mid-term shareholder loss of approximately 319.7 million yuan, an increase of about 263.5% year-on-year.
Zijin Mining Group (02899) announced its mid-term results, with a net profit attributable to shareholders of approximately 39.17 billion yuan, a year-on-year increase of 68.17%.
RECOMMEND
